Publications

  • Wakisaka K, Matsuo R, Matsumoto K, Nohara Y, Irie F, Wakisaka Y, Ago T, Nakashima N, Kamouchi M, Kitazono T.
    Non-linear association between body weight and functional outcome after acute ischemic stroke.
    Sci Rep. 2023 May 29;13(1):8697.
  • Ueki K, Matsuo R, Kuwashiro T, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study
    Stroke. 2023 Apr 6. doi: 10.1161/STROKEAHA.122.040958. Epub ahead of print. PMID: 37021567.
  • Ohya Y, Matsuo R, Sato N, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
    Modification of the effects of age on clinical outcomes through management of lifestyle-related factors in patients with acute ischemic stroke.
    J Neurol Sci. 2023 Feb 15;446:120589.
  • Irie F, Matsuo R, Nakamura K, Wakisaka Y, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Sex Differences in Long-Term Functional Decline after Ischemic Stroke: A Longitudinal Observational Study from the Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2023 Feb 8:1-8.
  • Ohya Y, Matsuo R, Sato N, Irie F, Nakamura K, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
    Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study.
    PLoS One. 2022 Jul 13;17(7):e0268481.
  • Fukuda K, Matsuo R, Kamouchi M, Kiyuna F, Sato N, Nakamura K, Hata J, Wakisaka Y, Ago T, Imaizumi T, Kai H, Kitazono T; FSR Investigators.
    Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long- Term Recurrence.
    Stroke. 2022 Jan;53(1):70-78.
  • Irie F, Matsuo R, Nakamura K, Wakisaka Y, Ago T, Kamouchi M, Kitazono T, Fukuoka Stroke Registry Investigators
    Sex Differences in the Risk of 30-Day Death After Acute Ischemic Stroke
    Neurol Clin Pract. 2021 Dec;11(6):e809-e816
  • Wakisaka Y, Matsuo R, Nakamura K, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2021;50(4):390-396.
  • Kiyohara T, Matsuo R, Hata J, Nakamura K, Wakisaka Y, Kamouchi M, Kitazono T, Ago T; FSR Investigators.
    β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke.
    Stroke. 2021;52(8):2621-2628.
  • Matsuo R, Ago T, Kiyuna F, Sato N, Nakamura K, Kuroda J, Wakisaka Y, Kitazono T; Fukuoka Stroke Registry Investigators.
    Smoking Status and Functional Outcomes After Acute Ischemic Stroke.
    Stroke. 2020;51(3):846-852.
  • Sato N, Matsuo R, Kiyuna F, Nakamura K, Hata J, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; collab on behalf of the Fukuoka Stroke Registry Investigators.
    Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism.
    Cerebrovasc Dis.2020;49(6):601-608.
  • Kuroda J, Matsuo R, Yamaguchi Y, Sato N, Kamouchi M, Hata J, Wakisaka Y, Ago　T, Kitazono T; Fukuoka Stroke Registry Investigators.
    Poor glycemic control and　posterior circulation ischemic stroke.
    Neurol Clin Pract. 2019;9(2):129-139.
  • Shono Y, Sugimori H, Matsuo R, Fukushima Y, Wakisaka Y, Kuroda J, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.
    Int J Stroke. 2018; 13(7):734-742.
  • Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Insulin resistance and clinical outcomes after acute ischemic stroke.
    Neurology. 2018; 90(17): e1470-1477.
  • Kiyuna F, Sato N, Matsuo R, Kamouchi M, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators.
    Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke.
    JAMA Netw Open. 2018;1(5):e182953.
  • Ogata T, Matsuo R, Kiyuna F, Hata J, Ago T, Tsuboi Y, Kitazono T, Kamouchi M; FSR Investigators.
    Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    J Am Heart Assoc. 2017; 6.
  • Wakisaka Y, Matsuo R, Hata J, Kuroda J, Kitazono T, Kamouchi M, Ago T; Fukuoka Stroke Registry Investigators.
    Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2017;43(1-2):82-89.
  • Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke.
    Stroke. 2017;48:3049-3056.
  • Ishikawa H, Wakisaka Y, Matsuo R, Makihara N, Hata J, Kuroda J, Ago T, Kitayama J, Nakane H, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2016; 42(5-6): 395-403.
  • Matsuo R, Michikawa T, Ueda K, Ago T, Nitta H, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Short-Term Exposure to Fine Particulate Matter and Risk of Ischemic Stroke.
    Stroke. 2016;47(12):3032-3034.
  • Matsuo R, Ago T, Hata J, Wakisaka Y, Kuroda J, Kuwashiro T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study.
    PLoS One. 2016;11(6):e0156790.
  • Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Cerebrovasc Dis. 2016;42(3-4):196-204.
  • Fukuda K, Kai H, Kamouchi M, Hata J, Ago T, Nakane H, Imaizumi T, Kitazono T; FSR Investigators; steering committee of the Fukuoka Stroke Registry included.
    Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry.
    Stroke. 2015;46(7):1832-9.
  • Irie F, Kamouchi M, Hata J, Matsuo R, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators.
    Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry.
    Stroke. 2015;46(2):471-6.
  • Matsuo R, Kamouchi M, Fukuda H, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators.
    Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.
    PLoS One. 2014;9(10):e110444.
  • Ogata T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Ago T, Sugimori H, Inoue T, Kitazono T; Fukuoka Stroke Registry.
    Gastrointestinal bleeding in acute ischemic stroke: recent trends from the fukuoka stroke registry.
    Cerebrovasc Dis Extra. 2014;4(2):156-64.
  • Wakisaka Y, Ago T, Kamouchi M, Kuroda J, Matsuo R, Hata J, Gotoh S, Isomura T, Awano H, Suzuki K, Fukuda K, Okada Y, Kiyohara Y, Ooboshi H, Kitazono T; REBIOS Investigators.
    Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke.
    J Neurol Sci. 2014;340(1-2):75-9.
  • Matsuo R, Kamouchi M, Ago T, Hata J, Shono Y, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T; FSR investigators.
    Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Geriatr Gerontol Int. 2014;14(4):954-9.
  • Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J, Ago T, Kuwashiro T, Sugimori H, Nakane H, Kitazono T; FSR Investigators.
    High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry.
    Hypertension. 2014;63(1):54-60.
  • Kiyohara T, Kamouchi M, Kumai Y, Ninomiya T, Hata J, Yoshimura S, Ago T, Okada Y, Kitazono T; Fukuoka Stroke Registry Investigators.
    ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack.
    Stroke. 2014;45(2):418-25.
  • Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.
    Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke – Research for Biomarkers in Ischemic Stroke (REBIOS).
    Metabolism. 2014;63(9):1093-103.
  • Matsuo R, Ago T, Hata J, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T, Kamouchi M; FSR Investigators.
    Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2014;23(6):1356-61.
  • Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T.
    The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry.
    Eur J Neurol. 2013;20(6):921-7.
  • Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.
    Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2013;22(8):e470-6.
  • Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T; FSR Investigators.
    Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry.
    BMJ Open.2013;3(11):e003678.
  • Makihara N, Kamouchi M, Hata J, Matsuo R, Ago T, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.
    Atherosclerosis. 2013;231(2):211-5.
  • Matsuo R, Ago T, Kamouchi M, Kuroda J, Kuwashiro T, Hata J, Sugimori H, Fukuda K, Gotoh S, Makihara N, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.
    Clinical significance of plasma VEGF value in ischemic stroke – research for biomarkers in ischemic stroke (REBIOS) study.
    BMC Neurol. 2013;13:32.
  • Tokami H, Ago T, Sugimori H, Kuroda J, Awano H, Suzuki K, Kiyohara Y, Kamouchi M, Kitazono T; REBIOS Investigators.
    RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke.
    Brain Res. 2013;1517:122-32.
  • Nakamura A, Ago T, Kamouchi M, Hata J, Matsuo R, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry.
    Stroke. 2013;44(11):3239-42.
  • Kuwashiro T, Kamouchi M, Ago T, Hata J, Sugimori H, Kitazono T.
    The factors associated with a functional outcome after ischemic stroke in diabetic patients: the Fukuoka Stroke Registry.
    J Neurol Sci. 2012;313(1-2):110-4.
  • Kuwashiro T, Sugimori H, Ago T, Kamouchi M, Kitazono T; FSR Investigators.
    Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: the Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2012;33(2):141-9.
  • Kamouchi M, Ueda K, Ago T, Nitta H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Relationship between asian dust and ischemic stroke: a time-stratified case-crossover study.
    Stroke. 2012;43(11):3085-7.
  • Kamouchi M, Kumagai N, Okada Y, Origasa H, Yamaguchi T, Kitazono T.
    Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese.
    Cerebrovasc Dis. 2012;34(5-6):351-7.
  • Kuwashiro T, Sugimori H, Kamouchi M, Ago T, Kitazono T, Iida M.
    Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2012;21(7):561-8.
  • Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T; FSR Investigators.
    Proteinuria and clinical outcomes after ischemic stroke.
    Neurology. 2012;78(24):1909-15.
  • Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, Fukushima Y, Sugimori H, Kitazono T; FSR Investigators.
    Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry.
    Stroke. 2011;42(10):2788-94.
  • Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M; Fukuoka Stroke Registry.; Hisayama study.
    Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study.
    Eur J Neurol. 2008;15(5):481-6.
  • Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M.
    Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study.
    Cerebrovasc Dis. 2008;25(5):417-22.
  • Kuroda J, Kitazono T, Ago T, Ninomiya T, Ooboshi H, Kamouchi M, Kumai Y, Hagiwara N, Yoshimura S, Tamaki K, Kusuda K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Asano K, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M.
    NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study.
    Eur J Neurol. 2007;14(10):1091-7.